Skopos Labs, Inc. Cytek Biosciences, Inc. Transaction History
Skopos Labs, Inc.
- $330 Million
- Q4 2024
A detailed history of Skopos Labs, Inc. transactions in Cytek Biosciences, Inc. stock. As of the latest transaction made, Skopos Labs, Inc. holds 1 shares of CTKB stock, worth $4. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1Holding current value
$4% of portfolio
0.0%About Cytek Biosciences, Inc.
- Ticker CTKB
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 134,627,008
- Market Cap $580M
- Description
- Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers ...